Recommended Reading

Bariatric News is teaming with Medtronic on this World Obesity Day on 4th March and asking you to join the global community to raise awareness on obesity as a chronic disease, its causes and consequences, and call for action for improved prevention and t

Eiger BioPharmaceuticals has announced positive results from the Phase 2 PREVENT study of Avexitide in patients with severe Post-Bariatric Hypoglycaemia (PBH), the outcomes were published in Journal of Clinical Endocrinology & Metabolism (Craig, C.M.